PHARMACIST LEAD PATIENT COUNSELLING: IMPACT ON QUALITY OF LIFE IN ASTHMA PATIENTS
DOI:
https://doi.org/10.22270/ijmspr.v3i3.20Keywords:
Patient counselling, Quality of life, Asthma patients, Chronic diseasesAbstract
Safe and effective drug therapy depends on patients being well informed about their medication. The proper use of drugs and patient education are vital for asthma management. Increasing patient’s knowl-edge about their asthma therapy is a necessary component of asthma management. This study was carried out to assess the patient counseling impact on quality of life (QOL) in asthma patients using SF 36questionnaire. In this study a total of hundred patients diagnosed with asthma were enrolled by considering the inclusion and exclusion criteria. Out of this, 50 (50%) patients were in intervention and 50 (50%) patients in the control group. As per our study it was found that the predominant risk factor for Asthma was fumes and smoking was found to be the major risk factor in males. After patient counseling intervention group showed improvement in QOL from the baseline to1st and 2nd follow-ups. But control group doesn’t show significant improvement in the QOL from the baseline to 1st and 2nd follow-ups. Physical activity and daily activity was also found to be increased during second follow-up in intervention group than in control group. Our study concluded that continuous education programs and counseling should be conducted for chronic diseases to emphasize and re-emphasize the importance of Quality of Life, to prevent recurrences, reduce progression of disease and ultimately minimize the hospitalization and there is a need of continuous pharmaceutical care services/ monitoring to improve the better quality of life.
References
William Kelly H and Christine A (2008), “Sorkness; Asthma in; Joseph T Dipiro, Pharmacotherapy, A Patho Physiologic Approach, VII Edition, pp. 463-494.
Kabila B, Sankar V (2011), “Risk Factor Assessment Study for Bronchial Asthma Among The Rural People”, Indian Journal of Pharmacy Practice, Vol. 4, No. 3 July to September.
World Health Organization (2007), “Global Surveillance, Prevention and Control of Chronic Respiratory Diseases: A Comprehensive Approach”,
Harrison’s Principles of Internal Medicine, 17th Edition, Published in 2008-Chapter 248.
Roger W and Cate W, Clinical Pharmacy and Therapeutics, 4th Edition, Churchill Livingstone Co. C25, Asthma:377
Ernst P, Fitzgerald J M, Spier S (1996), “Canadian Asthma Consensus Conference: Summary of Recommendations”, Can Respir J., Vol. 3, pp. 89-100.
The British Guidelines on Asthma Management 1995: Review and Position Statement, Thorax 1997, Vol. 52(Suppl), pp. S1-21
Lewis R K, Lasack N L, Lambert B L and Connor S E (1997), “Patient Counselling – A Focus on Maintenance Therapy”, Am J Health-Syst Pharm., Vol. 54, No. 18, pp. 2084-98.
Sonal S, Samiya K, Tinu J and Saraswathi R (2011), Legal Aspects of Patient Counselling: Need of the Hour - A Review”, IJRPC, Vol. 1, No. 2.
Shakeel Ahmed et al. (2013), “A Study on Impact of Pharmacist Mediated Patient Counselling on Quality of Life in Asthma Patients, at a Tertiary Care Hospital”, RGUHS J Pharm Sci, Vol. 3, No. 2, April June.
Benedicte leynaert et al. (2000), “Quality of Life in Allergic Rhinitis and Asthma A Population-based Study of Young Adults”, Am J Respir Crit Care Med., Vol. 162. pp. 1391-1396.
Rathan shyam M et al. (2013), “Role of Clinical Pharmacist in Impact of Patient Counselling in Asthmatic Patients”, JGTPS, Vol. 4, No. 2, April-June.
Ramanath K V , Nagakishore C H, Mahesh Kumar S, Balaji D B S S, Bhanuprakash M (2011), “A Study on Medication Adherence & Quality of Life in Asthma & Chronic Obstructive Pulmonary Diseases(COPD) of Rural Population in a Tertiary care Hospital”, Indo Global Journal of Pharmaceutical Sciences, Vol. 1, No. 4, pp. 315- 327
Published
How to Cite
Issue
Section
Copyright (c) 2017 Mohan P Linu
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
.